• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大新斯科舍省2002 - 2013年莱姆病流行病学

Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013.

作者信息

Hatchette Todd F, Johnston B Lynn, Schleihauf Emily, Mask Angela, Haldane David, Drebot Michael, Baikie Maureen, Cole Teri J, Fleming Sarah, Gould Richard, Lindsay Robbin

出版信息

Emerg Infect Dis. 2015 Oct;21(10):1751-8. doi: 10.3201/eid2110.141640.

DOI:10.3201/eid2110.141640
PMID:26401788
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4593424/
Abstract

Ixodes scapularis ticks, which transmit Borrelia burgdorferi, the causative agent of Lyme disease (LD), are endemic to at least 6 regions of Nova Scotia, Canada. To assess the epidemiology and prevalence of LD in Nova Scotia, we analyzed data from 329 persons with LD reported in Nova Scotia during 2002-2013. Most patients reported symptoms of early localized infection with rash (89.7%), influenza-like illness (69.6%), or both; clinician-diagnosed erythema migrans was documented for 53.2%. In a separate serosurvey, of 1,855 serum samples screened for antibodies to B. burgdorferi, 2 were borderline positive (both with an indeterminate IgG on Western blot), resulting in an estimated seroprevalence of 0.14% (95% CI 0.02%-0.51%). Although LD incidence in Nova Scotia has risen sharply since 2002 and is the highest in Canada (16/100,000 population in 2013), the estimated number of residents with evidence of infection is low, and risk is localized to currently identified LD-endemic regions.

摘要

肩突硬蜱传播莱姆病(LD)的病原体伯氏疏螺旋体,在加拿大新斯科舍省的至少6个地区为地方病。为评估新斯科舍省莱姆病的流行病学和患病率,我们分析了2002年至2013年期间新斯科舍省报告的329例莱姆病患者的数据。大多数患者报告有早期局限性感染的症状,如皮疹(89.7%)、流感样疾病(69.6%)或两者皆有;临床诊断的游走性红斑记录为53.2%。在一项单独的血清学调查中,在1855份筛查伯氏疏螺旋体抗体的血清样本中,有2份为临界阳性(两者在免疫印迹上的IgG均不确定),估计血清阳性率为0.14%(95%CI 0.02%-0.51%)。尽管自2002年以来新斯科舍省的莱姆病发病率急剧上升,且在加拿大最高(2013年为16/10万人口),但有感染证据的居民估计数量较低,且风险局限于目前确定的莱姆病流行地区。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/4593424/04e4555ff222/14-1640-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/4593424/b4d40fdf88bb/14-1640-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/4593424/34a39a7d44e4/14-1640-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/4593424/04e4555ff222/14-1640-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/4593424/b4d40fdf88bb/14-1640-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/4593424/34a39a7d44e4/14-1640-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/4593424/04e4555ff222/14-1640-F3.jpg

相似文献

1
Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013.加拿大新斯科舍省2002 - 2013年莱姆病流行病学
Emerg Infect Dis. 2015 Oct;21(10):1751-8. doi: 10.3201/eid2110.141640.
2
First isolation of Lyme disease spirochete, Borrelia burgdorferi, from blacklegged tick, Ixodes scapularis, removed from a bird in nova Scotia, Canada.首次从加拿大新斯科舍省一只鸟身上采集的黑脚蜱(肩突硬蜱)中分离出莱姆病螺旋体——伯氏疏螺旋体。
Can Commun Dis Rep. 1999 Sep 15;25(18):153-5.
3
Detection of Borrelia spp., Ehrlichia canis, Anaplasma phagocytophilum, and Dirofilaria immitis in Eastern Coyotes (Canis latrans) in Nova Scotia, Canada.加拿大新斯科舍省东部郊狼(犬属)中伯氏疏螺旋体属、犬埃立克体、嗜吞噬细胞无形体和犬恶丝虫的检测
J Wildl Dis. 2021 Jul 1;57(3):678-682. doi: 10.7589/JWD-D-20-00188.
4
Monitoring Risk: Tick and Public Participatory Surveillance in the Canadian Maritimes, 2012-2020.监测风险:2012 - 2020年加拿大海洋省份的蜱虫与公众参与式监测
Pathogens. 2021 Oct 6;10(10):1284. doi: 10.3390/pathogens10101284.
5
Lyme Disease, Anaplasmosis, and Babesiosis, Atlantic Canada.莱姆病、无形体病和巴贝斯虫病,加拿大大西洋地区。
Emerg Infect Dis. 2022 Jun;28(6):1292-1294. doi: 10.3201/eid2806.220443.
6
Frequency of Lyme disease in patients with tick contact and identification of ticks from Bolu province of Turkey.土耳其博卢省蜱接触患者莱姆病的发病频率及蜱的鉴定。
J Vector Borne Dis. 2024 Jul 1;61(3):452-460. doi: 10.4103/JVBD.JVBD_194_23. Epub 2024 Sep 21.
7
Prospective study on the incidence of infection by Borrelia burgdorferi sensu lato after a tick bite in a highly endemic area of Switzerland.瑞士高度流行地区蜱叮咬后伯氏疏螺旋体感染的前瞻性研究。
Ticks Tick Borne Dis. 2011 Sep;2(3):129-36. doi: 10.1016/j.ttbdis.2011.05.002. Epub 2011 Jul 28.
8
Ixodes scapularis ticks collected by passive surveillance in Canada: analysis of geographic distribution and infection with Lyme borreliosis agent Borrelia burgdorferi.在加拿大通过被动监测收集的肩突硬蜱:地理分布及莱姆病病原体伯氏疏螺旋体感染情况分析
J Med Entomol. 2006 May;43(3):600-9. doi: 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2.
9
Different Ecological Niches for Ticks of Public Health Significance in Canada.加拿大具有公共卫生意义的蜱虫的不同生态位
PLoS One. 2015 Jul 1;10(7):e0131282. doi: 10.1371/journal.pone.0131282. eCollection 2015.
10
Risk of Lyme disease: perceptions of residents of a Lone Star tick-infested community.莱姆病风险:孤星蜱虫肆虐社区居民的认知
Bull World Health Organ. 2001;79(10):916-25.

引用本文的文献

1
Lyme disease chemoprophylaxis prescribing before and after pharmacist prescriptive authority in Nova Scotia.新斯科舍省药剂师获得处方权前后的莱姆病化学预防用药处方情况。
Can Pharm J (Ott). 2024 Nov 15;158(1):47-54. doi: 10.1177/17151635241290519. eCollection 2025 Jan-Feb.
2
Retrospective validation of a rapid Lyme fluorescent immunoassay in differentiating Lyme arthritis from other musculoskeletal presentations in children in a Lyme-endemic region.在莱姆病流行地区,回顾性验证一种快速莱姆荧光免疫测定法在鉴别莱姆关节炎与儿童其他肌肉骨骼表现中的作用。
Microbiol Spectr. 2024 Jun 4;12(6):e0359323. doi: 10.1128/spectrum.03593-23. Epub 2024 Apr 29.
3

本文引用的文献

1
Environmental risk from Lyme disease in central and eastern Canada: a summary of recent surveillance information.加拿大中部和东部莱姆病的环境风险:近期监测信息总结
Can Commun Dis Rep. 2014 Mar 6;40(5):74-82. doi: 10.14745/ccdr.v40i05a01.
2
Clinical practice. Lyme disease.临床实践。莱姆病。
N Engl J Med. 2014 May 1;370(18):1724-31. doi: 10.1056/NEJMcp1314325.
3
The prevalence of Borrelia miyamotoi infection, and co-infections with other Borrelia spp. in Ixodes scapularis ticks collected in Canada.在加拿大采集的硬蜱(Ixodes scapularis)中,伯氏疏螺旋体(Borrelia miyamotoi)感染的流行情况,以及与其他伯氏疏螺旋体种的合并感染情况。
Current and future burden from Lyme disease in Québec as a result of climate change.
气候变化导致魁北克莱姆病当前及未来的负担。
Can Commun Dis Rep. 2023 Oct 1;49(10):446-456. doi: 10.14745/ccdr.v49i10a06.
4
Surveillance for Lyme disease in Canada, 2009-2019.2009 - 2019年加拿大莱姆病监测
Can Commun Dis Rep. 2022 May 5;48(5):219-227. doi: 10.14745/ccdr.v48i05a05.
5
Epidemiology and clinical manifestations of reported Lyme disease cases: Data from the Canadian Lyme disease enhanced surveillance system.报告莱姆病病例的流行病学和临床表现:来自加拿大莱姆病强化监测系统的数据。
PLoS One. 2023 Dec 15;18(12):e0295909. doi: 10.1371/journal.pone.0295909. eCollection 2023.
6
Profiling disease burden and Borrelia seroprevalence in Canadians with complex and chronic illness.分析患有复杂和慢性疾病的加拿大人的疾病负担和伯氏疏螺旋体血清流行率。
PLoS One. 2023 Nov 8;18(11):e0291382. doi: 10.1371/journal.pone.0291382. eCollection 2023.
7
Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease.用于莱姆病血清学诊断的改良两级检测酶免疫分析算法
Open Forum Infect Dis. 2022 Jun 6;9(7):ofac272. doi: 10.1093/ofid/ofac272. eCollection 2022 Jul.
8
Management and clinical outcomes of Lyme disease in acute care facilities in 2 endemic regions of Quebec, Canada: a multicentre retrospective cohort study.加拿大魁北克两个地方性流行地区急性护理机构莱姆病的管理和临床结局:一项多中心回顾性队列研究。
CMAJ Open. 2022 Jun 28;10(2):E570-E576. doi: 10.9778/cmajo.20210063. Print 2022 Apr-Jun.
9
Global seroprevalence and sociodemographic characteristics of in human populations: a systematic review and meta-analysis.全球人群中抗 抗体的血清流行率和社会人口学特征:系统评价和荟萃分析。
BMJ Glob Health. 2022 Jun;7(6). doi: 10.1136/bmjgh-2021-007744.
10
Laboratory Diagnosis of Lyme Borreliosis.莱姆病的实验室诊断。
Clin Microbiol Rev. 2021 Jan 27;34(2). doi: 10.1128/CMR.00018-19. Print 2021 Mar 17.
Parasit Vectors. 2014 Apr 15;7:183. doi: 10.1186/1756-3305-7-183.
4
Tick-borne pathogens in northwestern California, USA.美国加利福尼亚州西北部的蜱传病原体
Emerg Infect Dis. 2014 Mar;20(3):493-4. doi: 10.3201/eid2003.130668.
5
Comparative cost-effectiveness of two-tiered testing strategies for serodiagnosis of lyme disease with noncutaneous manifestations.针对非皮肤表现的莱姆病血清学诊断的两级检测策略的成本效益比较
J Clin Microbiol. 2013 Dec;51(12):4045-9. doi: 10.1128/JCM.01853-13. Epub 2013 Sep 25.
6
CDC estimates 300,000 US cases of Lyme disease annually.美国疾病控制与预防中心估计,美国每年有30万例莱姆病病例。
JAMA. 2013 Sep 18;310(11):1110. doi: 10.1001/jama.2013.278331.
7
Lyme arthritis: a comparison of presentation, synovial fluid analysis, and treatment course in children and adults.莱姆关节炎:儿童和成人的表现、滑膜液分析和治疗过程比较。
Arthritis Care Res (Hoboken). 2013 Dec;65(12):1986-90. doi: 10.1002/acr.22086.
8
Human Borrelia miyamotoi infection in the United States.美国的人类宫本疏螺旋体感染
N Engl J Med. 2013 Jan 17;368(3):291-3. doi: 10.1056/NEJMc1215469.
9
Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.采用 C6 肽 ELISA 试剂盒进行单阶段检测与莱姆病的双阶段检测相比。
Diagn Microbiol Infect Dis. 2013 Jan;75(1):9-15. doi: 10.1016/j.diagmicrobio.2012.09.003. Epub 2012 Oct 11.
10
Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.采用两种酶免疫分析法进行莱姆病的双层抗体检测,先用全细胞超声酶免疫分析法,再用 VlsE C6 肽酶免疫分析法。
Clin Infect Dis. 2011 Sep;53(6):541-7. doi: 10.1093/cid/cir464.